ATC Group: S01GX05 Lodoxamide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01GX05 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01G Decongestants and antiallergics
4 S01GX Other antiallergics
5 S01GX05 Lodoxamide

Active ingredients in S01GX05

Active Ingredient Description
Lodoxamide

Lodoxamide is a mast cell stabiliser that inhibits the in vivo Type I immediate hypersensitivity reaction in animals and man.

Related product monographs

Title Information Source Document Type  
ALOMIDE Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LOMIDE Eye drops, solution Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Canada (CA)

Finland (FI)

New Zealand (NZ)

South Africa (ZA)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.